s6y

DICE Therapeutics, Inc.

CIK
1645569
Industry
Pharmaceutical Preparations
Formerly
DiCE Molecules Holdings, LLC, DiCE MOLECULES HOLDINGS, LLC

Financials 8

  1. 10-Q Quarterly Report for period ending Jun 30, 2023
  2. 10-Q Quarterly Report for period ending Mar 31, 2023
  3. 10-K Annual Report for period ending Dec 31, 2022
  4. 10-Q Quarterly Report for period ending Sep 30, 2022
  5. 10-Q Quarterly Report for period ending Jun 30, 2022
  6. 10-Q Quarterly Report for period ending Mar 31, 2022
  7. 10-K Annual Report for period ending Dec 31, 2021
  8. 10-Q Quarterly Report for period ending Sep 30, 2021

News 19

  1. 8-K Current report filing
  2. 8-K Current report filing
  3. 8-K Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K Current report filing
  10. 8-K Current report filing

All 19 news filings

Ownership 85

  1. 4 Statement of changes in beneficial ownership of securities
  2. 4 Statement of changes in beneficial ownership of securities
  3. 4 Statement of changes in beneficial ownership of securities
  4. 4 Statement of changes in beneficial ownership of securities
  5. 4 Statement of changes in beneficial ownership of securities
  6. 4 Statement of changes in beneficial ownership of securities
  7. 4 Statement of changes in beneficial ownership of securities
  8. 4 Statement of changes in beneficial ownership of securities
  9. 4 Statement of changes in beneficial ownership of securities
  10. 4 Statement of changes in beneficial ownership of securities

All 85 ownership filings

Prospectus 24

  1. S-8 POS Post-effective amendment to a S-8 registration statement
  2. S-8 POS Post-effective amendment to a S-8 registration statement
  3. S-8 POS Post-effective amendment to a S-8 registration statement
  4. SC TO-T/A Third party tender offer statement
  5. SC TO-T/A Third party tender offer statement
  6. SC TO-T/A Third party tender offer statement
  7. SC TO-T Third party tender offer statement
  8. SC TO-C Written communication relating to an issuer or third party tender offer
  9. S-3ASR Automatic shelf registration statement of securities of well-known seasoned issuers
  10. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

All 24 prospectus filings

Proxies 5

  1. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  2. DEF 14A Definitive proxy statements
  3. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  4. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  5. DEF 14A Definitive proxy statements

Other 32

  1. 15-12G Notice of termination of registration of a class of securities under Section 12(g)
  2. EFFECT Notice of Effectiveness
  3. 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
  4. POSASR Post-effective Amendment to an automatic shelf registration statement on Form S-3ASR or Form F-3ASR
  5. POS AM Post-effective amendment to a registration statement that is not immediately effective upon filing
  6. SC 14D9/A Tender offer solicitation/recommendation statements filed under Rule 14d-9
  7. SC 14D9/A Tender offer solicitation/recommendation statements filed under Rule 14d-9
  8. SC 14D9/A Tender offer solicitation/recommendation statements filed under Rule 14d-9
  9. SC 14D9 Tender offer solicitation/recommendation statements filed under Rule 14d-9
  10. SC14D9C Written communication by the subject company relating to a third party tender offer

All 32 other filings